Cinnarizine

From Self-sufficiency
Revision as of 21:51, 27 August 2010 by 89.195.137.28 (Talk)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Cinnarizine
200px
Systematic (IUPAC) name
1-benzhydryl-4-cinnamyl-piperazine
Clinical data
Routes of
administration
Oral
Pharmacokinetic data
Biological half-life 3..4h
Identifiers
CAS Number 298-57-7
ATC code N07CA02 (WHO)
PubChem CID 2761
DrugBank APRD00332
Chemical data
Formula C26H28N2
Molar mass 368.514 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Cinnarizine (Stugeron, Stunarone) is an antihistamine which is mainly used for the control of nausea and vomiting due to motion sickness. Cinnarizine was first synthesized by Janssen Pharmaceutica in 1955. It is not available in the United States or Canada.

It acts by interfering with the signal transmission between vestibular apparatus of the inner ear and the vomiting centre of the hypothalamus. The disparity of signal processing between inner ear motion receptors and the visual senses is abolished, so that the confusion of brain whether the individual is moving or standing is reduced. Vomiting in motion sickness is actually a physiological compensatory mechanism of the brain to keep the individual from moving so that it can adjust to the signal perception.[citation needed]

Cinnarizine could be also viewed as a nootropic drug because of its vasorelaxating abilities (due to calcium channel blockage), which happen mostly in brain. It is also effectively combined with other nootropics, primarily Piracetam; in such combination each drug potentiate the other in boosting brain oxygen supply.[citation needed]

While this may be true, cinnarizine is also known to cause acute and chronic parkinsonism[citation needed], which strongly countersuggests its actual usefulness for improving neurohealth.

Cinnarizine can be used in scuba divers without an increased risk of central nervous system oxygen toxicity.[1]

Cinnarizine can cause drowsiness and blurred vision. It is important that users make sure their reactions are normal before driving, operating machinery, or doing any other jobs which could be dangerous if they are not fully alert or able to see well.[citation needed]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  • Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  • Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.



it:Cinnarizina

nl:Cinnarizine pl:Cynaryzyna pt:Cinarizina

ru:Циннаризин
  1. Arieli R, Shupak A, Shachal B, Shenedrey A, Ertracht O, Rashkovan G (1999). "Effect of the anti-motion-sickness medication cinnarizine on central nervous system oxygen toxicity". Undersea and Hyperbaric Medicine. 26 (2): 105–9. PMID 10372430. Retrieved 2009-03-30.